touchPODCAST

touchEXPERT OPINIONS for touchOPTHALMOLOGY

Listen to a leading expert in cataract and refractive surgery discuss the key considerations for intraocular lens selection and management of patients with cataracts and ocular comorbidities, including glaucoma, age-related macular degeneration and diabetic retinopathy.

The expert

• Dr Jennifer Loh – Loh Ophthalmology Associates, Miami, FL, USA

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc. and is jointly provided by USF Health and touchIME.

For further information visit our website: touchoncology.com/education/mab-biosimilars-in-the-treatment-of-solid-tumours-perspectives-for-pharmacists/

touchCONGRESS for touchONCOLOGY

Listen to renowned prostate cancer expert Prof. Oliver Sartor review key data presented at the recent EMSO 2023 congress on new and emerging data that addresses key clinical questions on the use of radiopharmaceuticals in advanced prostate cancer. He also discusses with two additional leading experts, Prof. Francesco Ceci and Dr Heather Jacene, how these data may apply in clinical practice.

Overview 

• Data reviews with Prof. Oliver Sartor

Clinical themes

1. Refining the use of PSMA-targeted radiopharmaceuticals through optimal patient selections

The internationally renowned expert faculty

• Prof. Oliver Sartor, Mayo Clinic, Rochester, MN, USA

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Advanced Accelerator Applications, and is jointly provided by USF Health and touchIME.

For further information visit our website: touchoncologyime.org/psma-targeted-radiopharmaceuticals-an-evolving-approach-to-prostate-cancer-management/

touchSATELLITE SYMPOSIUM for touchNEUROLOGY

Listen to this touchSATELLITE SYMPOSIUM on how to optimize diagnosis and care of patients with Alzheimer’s disease (AD), recorded live in October 2023 at the World Neurology Congress 2023 in Montreal, Canada. 

Dr Sharon Cohen (behavioural neurologist from Canada), the chair for the symposium, is joined by Prof. Sven Haller (neuroradiologist from Switzerland) and Dr Ronan Factora (geriatrician from the USA). 

The first session (03:40), led by Dr Sharon Cohen, focuses on the importance of an early and accurate diagnosis of AD in the DMT era. This is followed by the discussion of a patient case and audience Q&A (24:23).

In the second session (31:27), Prof. Sven Haller discusses the use of imaging and fluid biomarkers in the diagnostic process for. This is followed by the discussion of a patient case and audience Q&A (42:17).

In the third session (54:10), Dr Ronan Factora offers practical insights on how to achieve collaborative patient-centred care across the AD continuum. This is followed by the discussion of a patient case and audience Q&A (01:08:04).

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Eli Lilly and Company and is jointly provided by USF Health and touchIME.

For further information visit our website

touchCLINICAL PERSPECTIVES for touchNEUROLOGY

The expert

This touchPODCAST is for HCPs only.

For further information visit our website:  

touchCONGRESS for touchONCOLOGY

Listen to renowned experts in gynaecological oncology Prof. Nicole Concin, Dr Mansoor Raza Mirza and Dr Sandro Pignata review key data presented at ESGO 2023 on recent key developments in the management of patients with endometrial cancer. Aspects covered include the importance of molecular characterization and the latest clinical data for new and emerging agents, including immunotherapies and other agents, in the treatment of advanced or recurrent endometrial cancer. They also discuss how these latest developments may impact clinical practice.

Overview 

• Data reviews with Prof. Nicole Concin

Clinical themes

1. Molecular characterization of endometrial cancer: Latest developments 

The internationally renowned expert faculty

• Prof. Nicole Concin: Innsbruck, Austria,

This touchPODCAST is for HCPs outside of the USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline, and is provided by touchIME.

For further information visit our website: 

touchEXPERT OPINIONS for touchONCOLOGY

A leading expert explores the importance of molecular pathology and individual patient profiles in guiding personalized medicine in thyroid cancer to deliver optimal outcomes.

The expert

• Prof. Marcia Brose, Jefferson Torresdale Hospital, Philadelphia, PA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Bayer HealthCare Pharmaceuticals Inc. This activity is jointly provided by USF Health and touchIME. 

For further information visit: touchONCOLOGY.com 

touchEXPERT OPINIONS for touchENDOCRINOLOGY

A leading expert explores the importance of molecular pathology and individual patient profiles in guiding personalized medicine in thyroid cancer to deliver optimal outcomes.

The expert

• Prof Marcia Brose, Jefferson Torresdale Hospital, Philadelphia, PA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Bayer HealthCare Pharmaceuticals Inc. This activity is jointly provided by USF Health and touchIME. 

For further information visit: touchENDOCRINOLOGY.com

touchIN CONVERSATION for touchONCOLOGY

Listen to Dr Yasushi Goto (National Cancer Center Hospital, Tokyo, Japan) in conversation with Professor Paul Paik (Memorial Sloan Kettering Cancer Center, New York, USA) on how to optimize the management of patients with NSCLC and MET alterations. 

In Part 1 they respond to questions from the oncology and respiratory clinical communities on:

• Biomarker testing in advanced NSCLC

In Part 2, they respond to questions from the oncology and respiratory clinical communities on:

• Emerging mechanisms of resistance to EGFR-TKI therapy 

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from the healthcare Business of Merck KGaA, Darmstadt, Germany, and is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/met-alterations-nsclc-management/

touchIN CONVERSATION for touchRESPIRATORY

Listen to Dr Yasushi Goto (National Cancer Center Hospital, Tokyo, Japan) in conversation with Professor Paul Paik (Memorial Sloan Kettering Cancer Center, New York, USA) on how to optimize the management of patients with NSCLC and MET alterations. 

In Part 1 they respond to questions from the oncology and respiratory clinical communities on:

• Biomarker testing in advanced NSCLC

In Part 2, they respond to questions from the oncology and respiratory clinical communities on:

• Emerging mechanisms of resistance to EGFR-TKI therapy 

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from the healthcare Business of Merck KGaA, Darmstadt, Germany, and is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratoryime.org/met-alterations-nsclc-management/

touchTALKS for touchINFECTIOUS DISEASES

Listen to a leading expert from the Middle East address the issue of vaccine equity in COVID-19 vaccination, including the consequences of vaccine inequity and improving communication with the public.

The expert:

• Prof. Nada Melhem, American University of Beirut, Lebanon

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Moderna, Inc.  This activity is jointly provided by USF Health and touchIME.

This episode is Chapter 2 of 2.  To listen Chapter 1, where Dr Adidja Amani addresses COVID-19 vaccine inequity in Africa, please click here.

For further information visit our website www.touchinfectiousdiseases.com